A randomized double-blind controlled trial to assess the benefits of amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill schizophrenia patients (COMBINE): methods and design
2019 | journal article. A publication with affiliation to the University of Göttingen.
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
A randomized double-blind controlled trial to assess the benefits of amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill schizophrenia patients (COMBINE): methods and design
Schmidt-Kraepelin, C.; Feyerabend, S.; Engelke, C.; Riesbeck, M.; Meisenzahl-Lechner, E.; Gaebel, W. & Verde, P.-E. et al. (2019)
European Archives of Psychiatry and Clinical Neuroscience, 270(1) pp. 83-94. DOI: https://doi.org/10.1007/s00406-019-01063-4
Documents & Media
Details
- Authors
- Schmidt-Kraepelin, Christian; Feyerabend, Sandra; Engelke, Christina; Riesbeck, Mathias; Meisenzahl-Lechner, Eva; Gaebel, Wolfgang; Verde, Pablo-Emilio; Kolbe, Henrike; Correll, Christoph U.; Leucht, Stefan; Heres, Stephan; Kluge, Michael; Makiol, Christian; Neff, Andrea; Lange, Christina; Englisch, Susanne; Zink, Mathias; Langguth, Berthold; Poeppl, Timm; Reske, Dirk; Gouzoulis-Mayfrank, Euphrosyne; Gründer, Gerhard; Hasan, Alkomiet; Brockhaus-Dumke, Anke; Jäger, Markus; Baumgärtner, Jessica; Wobrock, Thomas ; Cordes, Joachim
- Issue Date
- 2019
- Journal
- European Archives of Psychiatry and Clinical Neuroscience
- ISSN
- 0940-1334
- eISSN
- 1433-8491
- Language
- English
